Cargando…
Clinicopathological characteristics and prognostic significance of HDAC11 protein expression in non-small cell lung cancer: a retrospective study
BACKGROUND: Although the prognosis of non-small cell lung cancer (NSCLC) can be assessed based on pathological type, disease stage and inflammatory indicators, the prognostic scoring model of NSCLC still needs to improve. HDAC11 is associated with poor prognosis of partial tumors, but its prognostic...
Autores principales: | Lu, Di, Ma, Zhiqiang, Huang, Di, Zhang, Jundong, Li, Jinfeng, Zhi, Peng, Zhang, Lizhong, Feng, Yingtong, Ge, Xiangwei, Zhai, Jinzhao, Jiang, Menglong, Zhou, Xin, Simone, Charles B., Neal, Joel W., Patel, Shruti Rajesh, Yan, Xiaolong, Hu, Yi, Wang, Jinliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271448/ https://www.ncbi.nlm.nih.gov/pubmed/35832445 http://dx.doi.org/10.21037/tlcr-22-403 |
Ejemplares similares
-
Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma
por: Huang, Renhong, et al.
Publicado: (2018) -
Lysine Acetylation/Deacetylation Modification of Immune-Related Molecules in Cancer Immunotherapy
por: Ding, Peng, et al.
Publicado: (2022) -
First‐line PD‐1/PD‐L1 inhibitors plus chemotherapy versus bevacizumab plus chemotherapy for advanced non‐squamous non‐small cell lung cancer: A Bayesian network meta‐analysis of randomized controlled trials
por: Zhai, Jinzhao, et al.
Publicado: (2022) -
Senescence marker protein 30 inhibits tumor growth by reducing HDAC4 expression in non-small cell lung cancer
por: Shao, Changjian, et al.
Publicado: (2021) -
WNT5A promotes the metastasis of esophageal squamous cell carcinoma by activating the HDAC7/SNAIL signaling pathway
por: Feng, Yingtong, et al.
Publicado: (2022)